Addressing Barriers to Improved Outcomes in African American Patients With Multiple Myeloma

CME: 1.0

Program Overview

Multiple myeloma is the second most common blood cancer in the United States, and its incidence in the African American population is twice that of Whites. This activity offers learners the opportunity to engage in clinical scenarios of multiple myeloma in African American patients presented as 3 case vignettes, each featuring an expert-led video clip. Through these customized cases, learners will hone their diagnostic and therapeutic skills by making specific decisions regarding the patients' clinical care and learning why their choices are appropriate or not based on current evidence and guidelines.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Identify African American-specific clinical features of multiple myeloma and their relevance to diagnosis, risk stratification, and treatment planning
  • Evaluate the appropriate use of novel agents and recommended treatment strategies in individualizing treatment of African American patients with multiple myeloma
  • Identify strategies for incorporating culturally sensitive approaches to engage, educate, and advocate for African American patients with multiple myeloma

Post a comment to this article